212 related articles for article (PubMed ID: 24387159)
1. Selective non-nucleoside inhibitors of human DNA methyltransferases active in cancer including in cancer stem cells.
Valente S; Liu Y; Schnekenburger M; Zwergel C; Cosconati S; Gros C; Tardugno M; Labella D; Florean C; Minden S; Hashimoto H; Chang Y; Zhang X; Kirsch G; Novellino E; Arimondo PB; Miele E; Ferretti E; Gulino A; Diederich M; Cheng X; Mai A
J Med Chem; 2014 Feb; 57(3):701-13. PubMed ID: 24387159
[TBL] [Abstract][Full Text] [Related]
2. Identification of a novel quinoline-based DNA demethylating compound highly potent in cancer cells.
Zwergel C; Schnekenburger M; Sarno F; Battistelli C; Manara MC; Stazi G; Mazzone R; Fioravanti R; Gros C; Ausseil F; Florean C; Nebbioso A; Strippoli R; Ushijima T; Scotlandi K; Tripodi M; Arimondo PB; Altucci L; Diederich M; Mai A; Valente S
Clin Epigenetics; 2019 May; 11(1):68. PubMed ID: 31060628
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and biological evaluation of 4-amino-N- (4-aminophenyl)benzamide analogues of quinoline-based SGI-1027 as inhibitors of DNA methylation.
Rilova E; Erdmann A; Gros C; Masson V; Aussagues Y; Poughon-Cassabois V; Rajavelu A; Jeltsch A; Menon Y; Novosad N; Gregoire JM; Vispé S; Schambel P; Ausseil F; Sautel F; Arimondo PB; Cantagrel F
ChemMedChem; 2014 Mar; 9(3):590-601. PubMed ID: 24678024
[TBL] [Abstract][Full Text] [Related]
4. New insights on the mechanism of quinoline-based DNA Methyltransferase inhibitors.
Gros C; Fleury L; Nahoum V; Faux C; Valente S; Labella D; Cantagrel F; Rilova E; Bouhlel MA; David-Cordonnier MH; Dufau I; Ausseil F; Mai A; Mourey L; Lacroix L; Arimondo PB
J Biol Chem; 2015 Mar; 290(10):6293-302. PubMed ID: 25525263
[TBL] [Abstract][Full Text] [Related]
5. 4-Anilino-7-pyridyl-3-quinolinecarbonitriles as Src kinase inhibitors.
Zhang N; Wu B; Boschelli DH; Golas JM; Boschelli F
Bioorg Med Chem Lett; 2009 Sep; 19(17):5071-4. PubMed ID: 19632113
[TBL] [Abstract][Full Text] [Related]
6. Discovery of Novel N-alkyl 4-anilinofuro[2,3-b]quinoline Derivatives (CIL-102 Derivatives) Against Castration-resistant Human Prostate Cancers.
Lo WF; Chou YW; Tseng CH; Shiu YH; Chen YW; Yang SC; Chen YL; Lin MF; Tzeng CC
Anticancer Agents Med Chem; 2015; 15(4):493-500. PubMed ID: 25612680
[TBL] [Abstract][Full Text] [Related]
7. Towards the chemoinformatic-based identification of DNA methyltransferase inhibitors: 2D- and 3D-similarity profile of screening libraries.
Yoo J; Medina-Franco JL
Curr Comput Aided Drug Des; 2012 Dec; 8(4):317-29. PubMed ID: 22734709
[TBL] [Abstract][Full Text] [Related]
8. Effects of a novel DNA methyltransferase inhibitor zebularine on human breast cancer cells.
Billam M; Sobolewski MD; Davidson NE
Breast Cancer Res Treat; 2010 Apr; 120(3):581-92. PubMed ID: 19459041
[TBL] [Abstract][Full Text] [Related]
9. A Quinoline-Based DNA Methyltransferase Inhibitor as a Possible Adjuvant in Osteosarcoma Therapy.
Manara MC; Valente S; Cristalli C; Nicoletti G; Landuzzi L; Zwergel C; Mazzone R; Stazi G; Arimondo PB; Pasello M; Guerzoni C; Picci P; Nanni P; Lollini PL; Mai A; Scotlandi K
Mol Cancer Ther; 2018 Sep; 17(9):1881-1892. PubMed ID: 29959201
[TBL] [Abstract][Full Text] [Related]
10. Discovery of a series of 2,5-diaminopyrimidine covalent irreversible inhibitors of Bruton's tyrosine kinase with in vivo antitumor activity.
Li X; Zuo Y; Tang G; Wang Y; Zhou Y; Wang X; Guo T; Xia M; Ding N; Pan Z
J Med Chem; 2014 Jun; 57(12):5112-28. PubMed ID: 24915291
[TBL] [Abstract][Full Text] [Related]
11. 5-Amino-2-aroylquinolines as highly potent tubulin polymerization inhibitors. Part 2. The impact of bridging groups at position C-2.
Lee HY; Chang JY; Nien CY; Kuo CC; Shih KH; Wu CH; Chang CY; Lai WY; Liou JP
J Med Chem; 2011 Dec; 54(24):8517-25. PubMed ID: 22060033
[TBL] [Abstract][Full Text] [Related]
12. Molecular modeling studies of the novel inhibitors of DNA methyltransferases SGI-1027 and CBC12: implications for the mechanism of inhibition of DNMTs.
Yoo J; Choi S; Medina-Franco JL
PLoS One; 2013; 8(4):e62152. PubMed ID: 23637988
[TBL] [Abstract][Full Text] [Related]
13. Design and synthesis of 4-[(s-triazin-2-ylamino)methyl]-N-(2-aminophenyl)-benzamides and their analogues as a novel class of histone deacetylase inhibitors.
Paquin I; Raeppel S; Leit S; Gaudette F; Zhou N; Moradei O; Saavedra O; Bernstein N; Raeppel F; Bouchain G; Fréchette S; Woo SH; Vaisburg A; Fournel M; Kalita A; Robert MF; Lu A; Trachy-Bourget MC; Yan PT; Liu J; Rahil J; MacLeod AR; Besterman JM; Li Z; Delorme D
Bioorg Med Chem Lett; 2008 Feb; 18(3):1067-71. PubMed ID: 18160287
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of novel 3-halo-3-nitroflavanones and their activities as DNA methyltransferase inhibitors in cancer cells.
Pechalrieu D; Dauzonne D; Arimondo PB; Lopez M
Eur J Med Chem; 2020 Jan; 186():111829. PubMed ID: 31757526
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and bioevalution of novel benzamides derivatives as HDAC inhibitors.
Li Y; Zhou Y; Qian P; Wang Y; Jiang F; Yao Z; Hu W; Zhao Y; Li S
Bioorg Med Chem Lett; 2013 Jan; 23(1):179-82. PubMed ID: 23206867
[TBL] [Abstract][Full Text] [Related]
16. Discovery of 4-((N-(2-(dimethylamino)ethyl)acrylamido)methyl)-N-(4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)benzamide (CHMFL-PDGFR-159) as a highly selective type II PDGFRα kinase inhibitor for PDGFRα driving chronic eosinophilic leukemia.
Wang Q; Liu F; Qi S; Qi Z; Yan XE; Wang B; Wang A; Wang W; Chen C; Liu X; Jiang Z; Hu Z; Wang L; Wang W; Ren T; Zhang S; Yun CH; Liu Q; Liu J
Eur J Med Chem; 2018 Apr; 150():366-384. PubMed ID: 29544149
[TBL] [Abstract][Full Text] [Related]
17. Identification and optimization of novel 6-acylamino-2-aminoquinolines as potent Hsp90 C-terminal inhibitors.
Jiang F; Guo AP; Xu JC; Wang HJ; Mo XF; You QD; Xu XL
Eur J Med Chem; 2017 Dec; 141():1-14. PubMed ID: 29028527
[TBL] [Abstract][Full Text] [Related]
18. JTC801 Induces pH-dependent Death Specifically in Cancer Cells and Slows Growth of Tumors in Mice.
Song X; Zhu S; Xie Y; Liu J; Sun L; Zeng D; Wang P; Ma X; Kroemer G; Bartlett DL; Billiar TR; Lotze MT; Zeh HJ; Kang R; Tang D
Gastroenterology; 2018 Apr; 154(5):1480-1493. PubMed ID: 29248440
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and structure-activity-relationships of 1H-imidazo[4,5-c]quinolines that induce interferon production.
Gerster JF; Lindstrom KJ; Miller RL; Tomai MA; Birmachu W; Bomersine SN; Gibson SJ; Imbertson LM; Jacobson JR; Knafla RT; Maye PV; Nikolaides N; Oneyemi FY; Parkhurst GJ; Pecore SE; Reiter MJ; Scribner LS; Testerman TL; Thompson NJ; Wagner TL; Weeks CE; Andre JD; Lagain D; Bastard Y; Lupu M
J Med Chem; 2005 May; 48(10):3481-91. PubMed ID: 15887957
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of new steroidal quinolines with antitumor properties.
Yang YT; Du S; Wang S; Jia X; Wang X; Zhang X
Steroids; 2019 Nov; 151():108465. PubMed ID: 31351940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
